Curepharma
ActiveDirectors
Directors
1 director, last change in 2024
Board 1
SARAVI
Current
Director (not named in the articles) · appointed in the act of 25-10-2022 · term without a fixed end · Private limited company · permanent representative: MALEKZADEH SARAVI Mahsa · listed in the 2025 annual accounts, filed on 18-08-2026
Permanent representatives 1
MALEKZADEH SARAVI Mahsa
Current
Permanent representative · appointed in the act of 25-10-2022 · for SARAVI
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Indien de vennootschap door meer dan één bestuurder wordt bestuurd, mag iedere bestuurder, alleen optredend, alle handelingen stellen die…”
deed of 03-01-2024Owners and capital
Shareholders
3 ownersOwners 3
- SARAVIparentSourceaccounts SARAVI 2025Equity €320,781 Profit of €72,139 in 2025 (profit of €85,602 in 2024)100%
- MasvanparentSourceown accounts 201799.8%
- Masvanconsolidating parentconsolidates
Mandate history
3 people, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| SARAVI |
|
| Marleen Masui |
|
| Olivier Vangrunderbeek |
|
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Vergoeding bestuurders, algemene vergadering beslist of mandaat al dan niet ten kosteloze titel”
Articles of association, deed of 03-01-2024 (in Dutch)